Similar to our data, treatment of the L6 muscle cells with metformin, a drug used clinically in the management of blood glucose levels in T2DM, increased tyrosine phosphorylation of IRS-1, phosphorylation of Akt, and restored the insulin-stimulated glucose uptake in the presence of palmitate [51]. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.